Overview Rating

Good

Technicals Analysis

100

0100

Financials Analysis

0100

Dr Reddy's Laboratories (NYSE:RDY) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Dr Reddy's Laboratories (RDY) operate in?

Dr Reddy's Laboratories is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Dr Reddy's Laboratories Stock (NYSE: RDY) stock price, news, charts, stock research, profile.

Open	$79.19
Close	$79.48
Volume / Avg.	187.32K / 213.23K
Day Range	$78.67 - $80.36
52 Wk Range	63.72 - 84.46
Market Cap	$13.24B
P/E Ratio	19.88
Dividend Yield	0.60%
Exchange	NYSE
RSI	46
Short Interest	1.69%
Days to Cover	13.61

Recent News

Dr. Reddy's to Acquire Haleon's Nicotine Addiction Drug

Dr.

Zacks

Haleon To Offload Non-Core Nicotine Therapy Business To Dr. Reddy's For Over $600M

Haleon has agreed to sell its nicotine replacement therapy business outside the U.S. to Dr. Reddy's Laboratories SA for £500 million ($632 million). This strategic move allows Haleon to focus on growth areas.

Vandana Singh

Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand

Indian pharmaceutical giants, including Sun Pharma and Cipla, seize the opportunity to develop affordable versions of Novo Nordisk's Wegovy weight-loss treatment. With patents set to expire by 2026-2032, these generics aim to address India's rising obesity and diabetes concerns, anticipating substantial market growth in the next decade.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$79.19
Close	$79.48
Volume / Avg.	187.32K / 213.23K
Day Range	$78.67 - $80.36
52 Wk Range	63.72 - 84.46
Market Cap	$13.24B
P/E Ratio	19.88
Dividend Yield	0.60%
Exchange	NYSE
RSI	46
Short Interest	1.69%
Days to Cover	13.61

About Dr. Reddy`s Laboratories Ltd.

Sector

Health Care

Industry

Pharmaceuticals

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant pres...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Dr Reddy's Laboratories (RDY) stock?

You can purchase shares of Dr Reddy's Laboratories (NYSE:RDY) through any online brokerage.

View our list of the best stock brokerages

Who are Dr Reddy's Laboratories (RDY) competitors?

Other companies in Dr Reddy's Laboratories’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

What is the forecast, or price target, for Dr Reddy's Laboratories (RDY) stock?

Dr Reddy's Laboratories has a consensus price target of $87.00.

What is the current price for Dr Reddy's Laboratories (RDY)?

The stock price for Dr Reddy's Laboratories (NYSE: RDY) is $79.48 last updated September 24, 2024 at 7:00 PM EDT.

Does Dr Reddy's Laboratories (RDY) pay a dividend?

A quarterly cash dividend of 0.38 per share of Class A Common Stock. The quarterly cash dividend was payable on August 12, 2022 to stockholders of record on July 8, 2022.

When is Dr Reddy's Laboratories (NYSE:RDY) reporting earnings?

Dr Reddy's Laboratories’s Q2 earnings are confirmed for Friday, October 25, 2024.

Is Dr Reddy's Laboratories (RDY) going to split?

There is no upcoming split for Dr Reddy's Laboratories.

What sector and industry does Dr Reddy's Laboratories (RDY) operate in?

Dr Reddy's Laboratories is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Top Stock Ideas Sent Daily — Join and Gain Your Edge